Standout Papers

Correlation of Computed Tomography and P... 1982 2026 1996 2011 1.1k
  1. Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria (2007)
    Haesun Choi, C Charnsangavej et al. Journal of Clinical Oncology
  2. Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033 (2008)
    Charles D. Blanke, Cathryn Rankin et al. Journal of Clinical Oncology
  3. Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer (2001)
    Michael S. Gordon, Kim Margolin et al. Journal of Clinical Oncology
  4. Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion (1982)
    Sewa S. Legha, Robert S. Benjamin et al. Annals of Internal Medicine
  5. Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 (2007)
    Robert G. Maki, J. Kyle Wathen et al. Journal of Clinical Oncology
  6. Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy (2003)
    Gunar K. Zagars, Matthew T. Ballo et al. Cancer
  7. Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group (2008)
    Michael C. Heinrich, Kouros Owzar et al. Journal of Clinical Oncology
  8. We Should Desist Using RECIST, at Least in GIST (2007)
    Robert S. Benjamin, Haesun Choi et al. Journal of Clinical Oncology

Immediate Impact

5 by Nobel laureates 4 from Science/Nature 82 standout
Sub-graph 1 of 17

Citing Papers

Ewing’s Sarcoma
2021 Standout
Challenges and Opportunities in Cancer Drug Resistance
2020 Standout
13 intermediate papers

Works of Robert S. Benjamin being referenced

Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients
2017
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
2008 Standout
and 9 more

Author Peers

Author Last Decade Papers Cites
Robert S. Benjamin 13510 11394 5378 474 24.7k
Ian Judson 16160 10674 3265 402 27.4k
Samuel Singer 16327 7981 3846 326 28.2k
Paolo G. Casali 18356 8147 4046 424 24.0k
Robert G. Maki 17885 9578 3543 377 25.7k
Peter W. T. Pisters 17018 16521 2789 293 26.7k
Jean‐Yves Blay 25741 18978 5630 1.2k 43.9k
M. van Glabbeke 17691 15322 1708 195 34.8k
George D. Demetri 23206 10951 3125 342 37.2k
Antoîne Italiano 8842 8717 2098 606 16.8k
Peter Hohenberger 8759 4938 1912 363 13.4k

All Works

Loading papers...

Rankless by CCL
2026